Gene editing has emerged as a powerful approach for targeting the genetic causes of disease, but getting the editing ...
STING" molecular switch drives Alzheimer's brain inflammation. Blocking this switch protects synapses in new study.
Myofibrillar myopathy type 6 (MFM6) is a rare genetic muscle disorder that leads to severe muscle weakness and a drastically ...
A new study published in Engineering reveals that obakulactone (OL), a natural tetracyclic triterpenoid isolated from Phellodendri cortex, exerts a ...
We recently compiled a list of the Top 10 AI-Powered Biotech Stocks to Buy Right Now. Kymera Therapeutics, Inc. is among the ...
Cambridge, UK, 24th April 2026 - Amphista Therapeutics (“the Company” or “Amphista”), a leader in the discovery and development of ...
The FDA granted fast track designation to KT-621 for treating patients with moderate to severe eosinophilic asthma, according ...
A widely publicised Cochrane review published on April 16, 2026, set out to synthesise evidence on the efficacy and safety of amyloid β-targeting monoclonal antibodies for Alzheimer's disease.1 The ...
US scientists have built a high-throughput biological platform that could speed up the search for rare-earth separation ...
Indian Defence Review on MSN
Scientists uncover a hidden bone switch that could transform osteoporosis treatment
A newly identified receptor could redefine how scientists treat bone loss by directly restoring the balance between bone ...
At AACR 2026, prominent cancer researchers discussed the latest advances in mitigating tumor evasion, targeting cancer ...
(NASDAQ:KYMR) is among the best biotech stocks. TheFly reported on April 13 that KYMR announced that the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results